Literature DB >> 22875452

An inside view: VEGF receptor trafficking and signaling.

Michael Simons1.   

Abstract

Vascular endothelial growth factors (VEGF) and their receptors play a central role in the development of cardiovascular system and in vasculature-related processes in the adult organism. Given the critical role of this signaling cascade, intricate control systems have evolved to regulate its function. A new layer of added complexity has been the demonstration of the importance of endocytosis and intracellular trafficking of VEGF receptors in the regulation of VEGF signaling. In this review, we consider an evolving link between VEGF receptor endocytosis, trafficking, and signaling and their biological function.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22875452      PMCID: PMC4037811          DOI: 10.1152/physiol.00016.2012

Source DB:  PubMed          Journal:  Physiology (Bethesda)        ISSN: 1548-9221


  68 in total

1.  Thrombospondin-1 inhibits VEGF receptor-2 signaling by disrupting its association with CD47.

Authors:  Sukhbir Kaur; Gema Martin-Manso; Michael L Pendrak; Susan H Garfield; Jeff S Isenberg; David D Roberts
Journal:  J Biol Chem       Date:  2010-10-05       Impact factor: 5.157

Review 2.  Increasing traffic on vascular routes.

Authors:  Martina Santambrogio; Donatella Valdembri; Guido Serini
Journal:  Mol Aspects Med       Date:  2011-04-23

Review 3.  Endocytosis and signaling.

Authors:  Harald W Platta; Harald Stenmark
Journal:  Curr Opin Cell Biol       Date:  2011-04-05       Impact factor: 8.382

Review 4.  Signal transduction by vascular endothelial growth factor receptors.

Authors:  Sina Koch; Sònia Tugues; Xiujuan Li; Laura Gualandi; Lena Claesson-Welsh
Journal:  Biochem J       Date:  2011-07-15       Impact factor: 3.857

Review 5.  Endocytic control of growth factor signalling: multivesicular bodies as signalling organelles.

Authors:  Radek Dobrowolski; Edward M De Robertis
Journal:  Nat Rev Mol Cell Biol       Date:  2011-11-23       Impact factor: 94.444

6.  Neuropilin-1 promotes VEGFR-2 trafficking through Rab11 vesicles thereby specifying signal output.

Authors:  Kurt Ballmer-Hofer; Anneli E Andersson; Laura E Ratcliffe; Philipp Berger
Journal:  Blood       Date:  2011-05-17       Impact factor: 22.113

Review 7.  Molecular mechanisms and clinical applications of angiogenesis.

Authors:  Peter Carmeliet; Rakesh K Jain
Journal:  Nature       Date:  2011-05-19       Impact factor: 49.962

8.  Regulation of vascular endothelial growth factor receptor 2 trafficking and angiogenesis by Golgi localized t-SNARE syntaxin 6.

Authors:  Venkatraman Manickam; Ajit Tiwari; Jae-Joon Jung; Resham Bhattacharya; Apollina Goel; Debabrata Mukhopadhyay; Amit Choudhury
Journal:  Blood       Date:  2010-11-09       Impact factor: 22.113

9.  The cytoplasmic domain of neuropilin 1 is dispensable for angiogenesis, but promotes the spatial separation of retinal arteries and veins.

Authors:  Alessandro Fantin; Quenten Schwarz; Kathryn Davidson; Eduardo M Normando; Laura Denti; Christiana Ruhrberg
Journal:  Development       Date:  2011-08-18       Impact factor: 6.868

Review 10.  Molecular mechanism and physiological functions of clathrin-mediated endocytosis.

Authors:  Harvey T McMahon; Emmanuel Boucrot
Journal:  Nat Rev Mol Cell Biol       Date:  2011-07-22       Impact factor: 94.444

View more
  67 in total

1.  Combined therapy with thrombospondin-1 type I repeats (3TSR) and chemotherapy induces regression and significantly improves survival in a preclinical model of advanced stage epithelial ovarian cancer.

Authors:  Samantha Russell; Mark Duquette; Joyce Liu; Ronny Drapkin; Jack Lawler; Jim Petrik
Journal:  FASEB J       Date:  2014-11-13       Impact factor: 5.191

2.  Computational model of VEGFR2 pathway to ERK activation and modulation through receptor trafficking.

Authors:  Wan Hua Tan; Aleksander S Popel; Feilim Mac Gabhann
Journal:  Cell Signal       Date:  2013-08-29       Impact factor: 4.315

3.  Transmembrane protein ESDN promotes endothelial VEGF signaling and regulates angiogenesis.

Authors:  Lei Nie; Xiaojia Guo; Leila Esmailzadeh; Jiasheng Zhang; Abolfazl Asadi; Mark Collinge; Xuan Li; Jun-Dae Kim; Melissa Woolls; Suk-Won Jin; Alexandre Dubrac; Anne Eichmann; Michael Simons; Jeffrey R Bender; Mehran M Sadeghi
Journal:  J Clin Invest       Date:  2013-11-01       Impact factor: 14.808

Review 4.  Regulation of signaling interactions and receptor endocytosis in growing blood vessels.

Authors:  Mara E Pitulescu; Ralf H Adams
Journal:  Cell Adh Migr       Date:  2014       Impact factor: 3.405

5.  Revival of the VEGF ligand family?

Authors:  Simone P Niclou
Journal:  Neuro Oncol       Date:  2018-10-09       Impact factor: 12.300

6.  Profilin phosphorylation as a VEGFR effector in angiogenesis.

Authors:  Michael Simons; Martin A Schwartz
Journal:  Nat Cell Biol       Date:  2012-10       Impact factor: 28.824

7.  Targeting prion-like protein doppel selectively suppresses tumor angiogenesis.

Authors:  Taslim A Al-Hilal; Seung Woo Chung; Jeong Uk Choi; Farzana Alam; Jooho Park; Seong Who Kim; Sang Yoon Kim; Fakhrul Ahsan; In-San Kim; Youngro Byun
Journal:  J Clin Invest       Date:  2016-03-07       Impact factor: 14.808

Review 8.  Customizable biomaterials as tools for advanced anti-angiogenic drug discovery.

Authors:  Eric H Nguyen; William L Murphy
Journal:  Biomaterials       Date:  2018-07-26       Impact factor: 12.479

Review 9.  Endothelial epsins as regulators and potential therapeutic targets of tumor angiogenesis.

Authors:  Kai Song; Hao Wu; H N Ashiqur Rahman; Yunzhou Dong; Aiyun Wen; Megan L Brophy; Scott Wong; Sukyoung Kwak; Diane R Bielenberg; Hong Chen
Journal:  Cell Mol Life Sci       Date:  2016-08-29       Impact factor: 9.261

10.  Motif mimetic of epsin perturbs tumor growth and metastasis.

Authors:  Yunzhou Dong; Hao Wu; H N Ashiqur Rahman; Yanjun Liu; Satish Pasula; Kandice L Tessneer; Xiaofeng Cai; Xiaolei Liu; Baojun Chang; John McManus; Scott Hahn; Jiali Dong; Megan L Brophy; Lili Yu; Kai Song; Robert Silasi-Mansat; Debra Saunders; Charity Njoku; Hoogeun Song; Padmaja Mehta-D'Souza; Rheal Towner; Florea Lupu; Rodger P McEver; Lijun Xia; Derek Boerboom; R Sathish Srinivasan; Hong Chen
Journal:  J Clin Invest       Date:  2015-11-16       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.